Endothelial cell expression patterns
AssigneeThe Johns Hopkins University
InventorsEleanor Carson-Walter, Brad St. Croix, Kenneth W. Kinzler, Bert Vogelstein
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Johns Hopkins University
InventorsEleanor Carson-Walter, Brad St. Croix, Kenneth W. Kinzler, Bert Vogelstein
Estimating the term…
To gain a better understanding of tumor angiogenesis, new techniques for isolating endothelial cells (ECs) and evaluating gene expression patterns were developed. When transcripts from ECs derived from normal and malignant colorectal tissues were compared with transcripts from non-endothelial cells, over 170 genes predominantly expressed in the endothelium were identified. Comparison between normal- and tumor-derived endothelium revealed 79 differentially expressed genes, including 46 that were specifically elevated in tumor-associated endothelium. Experiments with representative genes from this group demonstrated that most were similarly expressed in the endothelium of primary lung, breast, brain, and pancreatic cancers as well as in metastatic lesions of the liver. These results demonstrate that neoplastic and normal endothelium in humans are distinct at the molecular level, and have significant implications for the development of anti-angiogenic therapies in the future.
An isolated molecule comprising an antibody variable region which specifically binds to an extracellular domain of TEM 3 protein as shown in SEQ ID NO:
A method of inhibiting neoangiogenesis, comprising:
A method of inhibiting tumor growth, comprising:
An isolated molecule comprising an antibody variable region which specifically binds to TEM 3 protein as shown in SEQ ID NO:
Dependencies are inferred from the claim text.